Pacira BioSciences Inc

Pacira BioSciences insider buying shows executive confidence in its non‑opioid pipeline—analyzing why the CAO’s RSU purchase could signal future growth or volatility.

Pacira BioSciences insider sales reveal routine portfolio moves, not a downturn—investors should monitor filings for strategy shifts.